scPharmaceuticals Inc (SCPH)
3.49
+0.13
(+3.87%)
USD |
NASDAQ |
Nov 21, 16:00
3.31
-0.18
(-5.16%)
After-Hours: 20:00
scPharmaceuticals Debt to Equity Ratio: 1.664 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.664 |
| June 30, 2024 | 4.323 |
| March 31, 2024 | 1.603 |
| December 31, 2023 | 1.043 |
| Date | Value |
|---|---|
| September 30, 2023 | 0.7785 |
| June 30, 2023 | 0.595 |
| March 31, 2023 | 0.4914 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.4914
Minimum
Mar 2023
4.323
Maximum
Jun 2024
1.500
Average
1.043
Median
Dec 2023
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 125.07M |
| Total Liabilities (Quarterly) | 94.36M |
| Shareholders Equity (Quarterly) | 30.71M |
| Current Ratio | 8.080 |
| Net Debt Paydown Yield | -1.17% |